Wyden Announces Finance Committee Hearing on Big Pharma’s Tax Avoidance Schemes
WASHINGTON, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., will convene a committee hearing on Thursday, May 11th, 2023 titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The hearing will take place at 10:00 a.m. in Room 215 of the Dirksen Senate Office Building.
The witnesses at Thursday’s hearing will be:
- Brad W. Setser, Whitney Shepherdson Senior Fellow, Council on Foreign Relations
- Diane M. Ring, Professor of Law, Boston College Law School
- William Morris, Deputy Global Tax Policy Leader, PwC
- Daniel Bunn, President and CEO, Tax Foundation
Who: Senate Finance Committee
What: Committee hearing on Big Pharma’s tax avoidance schemes and the effects of the 2017 Republican tax law.
Where: 215 Dirksen Senate Office Building
Washington, D.C. 20510
When: Thursday, May 11th, 2023
Media are encouraged to attend the hearing or to view the webcast and witness testimony at http://finance.senate.gov/hearings.
Next Article Previous Article